𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification of somatostatin receptors in human small cell lung carcinoma

✍ Scribed by Uri Sagman; J. Brendan Mullen; Kalman Kovacs; Robert Kerbel; Robert Ginsberg; Jean-Claude Reubi


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
592 KB
Volume
66
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Lack of expression for the suppressor PM
✍ Ping Zhang; Wai Chin; Louis T.C. Chow; Andrew S.K. Chan; Anthony P.C. Yim; Sing- πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 884 KB

The promyelocytic leukemia (PML) gene, which encodes a transformation and growth suppressor, was first identified at the chromosomal translocation break point t(15;17) in acute promyelocytic leukemia (PML). To determine if the PML gene might be involved in other neoplasias such as lung cancer, PML e

Treatment of small cell lung carcinoma i
✍ Esther Dajczman; Li Yi Fu; David Small; Norman Wolkove; Harvey Kreisman πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 625 KB

## BACKGROUND. The number of elderly people with small cell lung carcinoma (SCLC) is increasing and currently nearly 25% are older than 70 years. Elderly patients may not tolerate intensive therapy and, therefore, often do not receive such treatment. Additionally, age may be an independent predicto

Meningeal carcinomatosis in small cell c
✍ Oster, Martin W. ;Fetell, Michael πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 427 KB

## Abstract Small cell carcinoma of the lung is extremely sensitive to chemotherapy and radiation therapy. We describe the case of a patient who had a complete response to such treatment but relapsed with meningeal carcinomatosis. We propose that prophylactic therapy to the spinal cord as well as t

Urokinase-mediated posttranscriptional r
✍ Nunzia Montuori; Amalia Mattiello; Alessandro Mancini; Paola Taglialatela; Mario πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 371 KB

## Abstract The urokinase‐type plasminogen activator (uPA) and its cellular receptor (uPAR) are involved in the proteolytic cascade required for tumor cell dissemination and metastasis, and are highly expressed in many human tumors. We have recently reported that uPA, independently of its enzymatic